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Abstract 
 
Purpose: Living with a melanoma diagnosis can be challenging. We aimed to assess the feasibility, 
acceptability, and perceived value of a nurse-led intervention that utilised patient-reported outcome 
(PRO) measures to identify and address the supportive care needs of newly diagnosed patients with 
Stage I/II melanoma over the first 4 months post-diagnosis. 
Methods: We conducted an exploratory, repeated-measures, single-arm, feasibility trial. One baseline 
(4 weeks post-diagnosis; T1) and one follow-up intervention session (4 weeks after wide local 
excision; T3) took place, two months apart. Patient survey data were collected monthly, at four 
assessment points (T1-T4), followed by exit interviews. 
Results: A recruitment rate of 55% (10/18) was achieved. The skin cancer nurse specialist (CNS) 
performed 19 in-clinic patient assessments within 6 months. One patient missed their follow-up 
intervention session (90% retention rate). Three participants (30%) were lost to follow-up at T4. 
Patients endorsed the standardised use of easy-to-use PRO measures as a means to help them 
shortlist, report and prioritise their needs. The CNS viewed the intervention as a highly structured 
activity that allowed tailoring support priority needs. A sizeable reduction in information needs was 
found from T1 to T4 (Standardised Response Mean [SRM] change=-0.99; p<0.05). From T1 to T2, 
significant reductions in psychological (SRM change=-1.18; p<0.001), practical (SRM change=-0.67; 
p<0.05) and sexuality needs (SRM change=-0.78; p<0.05) were observed. 
Conclusions: The intervention appears to be feasible in clinical practice and acceptable to both 
patients with newly diagnosed melanoma and clinicians. Future research is warranted to test its 
effectiveness against standard care. 
 
Keywords: Melanoma; supportive care needs; patient-reported outcome measures; cancer nurse 
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Highlights (for review) 
 Nurse-led, PRO measure-driven consultations to identify and address the supportive care 
needs of newly diagnosed patients with melanoma are feasible and acceptable in clinical 
practice. 
 Patients endorsed the standardised use of easy-to-use PRO measures as a means to help 
them shortlist, report and prioritise their needs.  
 The skin CNS viewed the intervention as a highly structured activity that allowed tailoring 
support priority needs. 
 The intervention could be associated with (a) reduction in information needs from the point of 
diagnosis throughout the first four months post-diagnosis, and (b) reduction in psychological, 
patient care and support and sexuality needs in the month following the baseline intervention 
session. 
*Highlights (for review)
Background 
The past decades have seen a steady increase in annual rates of melanoma within the UK (Arnold et 
al., 2014). In 2012, 14,445 people in the UK (4.4% of all cancer cases) were diagnosed with 
melanoma (International Agency for Research on Cancer, 2012), which is now ranked fifth behind the 
leading cancers of breast, lung, colon/rectum and prostate (International Agency for Research on 
Cancer, 2012). Living with and living beyond melanoma can be challenging (Hajdarevic et al., 2014); 
yet, little is known about the specific healthcare needs of this patient population. Recent evidence 
suggests that up to 25% of patients may have unmet needs in the mid- to long-term after primary 
treatment (Molassiotis et al., 2014). Negative psychosocial effects of a melanoma diagnosis may 
include emotional hardship due to altered body image, adverse effects on relationships, fear of the 
sun, uncertainty about the future, and on-going symptoms such as pain and lymphedema (Stamataki 
et al., 2015). Effectively supporting people with melanoma means offering nursing care that takes their 
healthcare needs into consideration (Hansen, 2014). 
Comprehensive needs assessments are now considered an important component of cancer care 
practice (National Cancer Action Team, 2013; Young et al., 2012). Key government initiatives and 
policy guidelines advocate for the needs of people with cancer (Department of Health, 2007; National 
Cancer Action Team, 2013; National Institute for Clinical Excellence, 2004; NHS Scotland, 2008; 
Scottish Government, 2016) and skin cancer (Hansen, 2014) being addressed to minimise distress, 
improve the experience of care, and reduce healthcare costs through effective self-management. 
Such needs assessments are often facilitated through use of self-report questionnaires ±known as 
patient-reported outcome (PRO) measures (Valderas and Alonso, 2008)± that collect information from 
care recipients about their perceived healthcare needs or concerns (Richardson et al., 2007). 
&OLQLFLDQV FDQ XVH WKLV LQIRUPDWLRQ WR RIIHU FDUH WKDW LV WDLORUHG WR D SHUVRQ¶V XQLTXH QHHGV
(Kotronoulas et al., 2017; Kotronoulas et al., 2017b; Kotronoulas et al., 2014).  
There is evidence, however, suggesting that clinicians in busy clinical settings often fail to assess 
SDWLHQWV¶QHHGVDQGPDNHDSSURSULDWHDQGWLPHO\UHIHUUDOV(Kasparian, 2013). One reason may be the 
fiscal and human resource challenges that healthcare systems currently face, which could deter 
clinical teams from implementing novel care interventions. Another reason may be that clinicians do 
QRW V\VWHPDWLFDOO\ XVH WRROV LQWR WKHLU FXUUHQW ZRUNIORZV WKDW FDQ KHOS WKHP LGHQWLI\ RQH¶V XQPHW
needs. Enhancing care in busy clinical settings means meeting end users¶ EH LW FDUH UHFLSLHQWV RU
clinicians) requirements, priorities and expectations for care interventions that are low-
cost/maintenance and easy to learn/deliver (Evans-Lacko et al., 2010; Francke et al., 2008; Mair et 
al., 2012; Scottish Intercollegiate Guidelines Network, 2015). 
Given the afore-mentioned gaps, we aimed to test a nurse-led, PRO measures-driven intervention to 
enhance identification and management of the supportive care needs of people with newly diagnosed 
melanoma. Nurses are considered to be the most appropriate health professionals to assess PRO 
measures as they are more receptive to and give greater weight to such information (Greenhalgh et 
al., 2005). Therefore, the aim of this study was to assess the feasibility, acceptability and perceived 
value of a needs assessment intervention for newly diagnosed patients with Stage I or II melanoma 
over the first four months post-diagnosis. Secondary objectives included exploration of (a) the 
prevalence and intensity of reported supportive care neeGV DQG E SDWWHUQV RI FKDQJH LQ SDWLHQWV¶
supportive care needs over time. 
In accordance to the objectives above, the primary research questions were as follows: 
1. What is the feasibility of a PRO measure-driven, nurse-led needs assessment/management 
intervention for newly diagnosed patients with melanoma in terms of patient 
availability/recruitment, time and resource requirements, missing data, and patient retention? 
2. What is the acceptability of the intervention for newly diagnosed patients with melanoma in 
terms of adherence, perceived burden, and timing? 
3. What is the perceived value of the intervention in supporting patients with melanoma and 
enhancing health care services offered? 
Secondary research questions included the following: 
4. What is the prevalence of supportive care needs of newly diagnosed patients with melanoma 
within the first 4 months after initial diagnosis? 
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5. How do supportive care needs of patients with melanoma change within the first 4 months 
after initial diagnosis when participating in the intervention? What is the extent of any change? 
 
Methods 
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement was 
employed to guide reporting of this study (von Elm et al., 2007). The study received a favourable 
ethical opinion from the West of Scotland REC 3 (15/WS/0226). 
 
Study Design and Setting 
An exploratory, repeated-measures, single-arm, feasibility trial was conducted at out-patient clinics 
within one NHS board in Scotland. The adopted study design is particularly suitable for early-phase 
H[SORUDWLRQRIDQLQWHUYHQWLRQ¶VIHDVLELOLty and acceptability. 
 
Sample 
Patients: A convenience sample of newly diagnosed patients with melanoma was identified by 
members of the melanoma multidisciplinary team and recruited during weekly meetings. Patients 
were invited to take part if they were: (a) Diagnosed with melanoma Stage I or II regardless of tumour 
thickness. (b) Within 1 month post-initial diagnosis following a multidisciplinary team meeting. (c) 
Aged 18 years or over. (d) Deemed by a member of the multidisciplinary team to be physically and 
psychologically fit to participate. (e) Able to read and write English. (f) Able to provide written informed 
consent. Patients not meeting the afore-mentioned criteria were excluded. 
Health Professionals: The skin cancer nurse specialist employed within the participating NHS board 
was invited to the study and asked to provide written informed consent. 
 
The intervention 
7KH LQWHUYHQWLRQ FRQVLVWHG RI D D SDFN RI ³LQWHUYHQWLRQ 352 PHDVXUHV´ WKDW DLPHG WR LGHQWLI\ WKH
supportive care needs of study participants, and (b) face-to-face patient consultations with the skin 
cancer nurse specialist that were driven by information gleaned from the intervention PRO measures. 
The intervention PRO measures pack comprised the National Comprehensive CancHU 1HWZRUN¶V
(NCCN) Distress Thermometer and Problem Checklist (DT&PC) (National Comprehensive Cancer 
Network, 2012), and the Supportive Care Needs Survey-Melanoma module (SCNS-Melanoma) 
(McElduff et al., 2004)&RPELQLQJWKHVHYDOLGDWHGDQGEULHIWRROVLQWRDQµLQWHUYHQWLRQ352PHDVXUH¶
ensured that both generic and melanoma-specific needs can be identified quickly during 
consultations. 
At the time of each intervention session, participants were asked to complete the intervention PRO 
measures in a quiet room in the hospital immediately prior to their consultation with the nurse 
specialist. Completed intervention PRO measures were then passed on the nurse specialist for 
review. The subsequent consultation was based on information collected on priority supportive care 
needs that was used to direct nursing actions, provide tailored support and intervene accordingly. At 
the end of the consultation, the nurse specialist documented all interventions initiated and actions 
taken in a case report form. The nurse specialist was given no specific advice about how to respond 
to patient needs. 
Implementation of this person-centred model was further enhanced by working with people with 
melanoma throughout the study in an attempt to ensure that the intervention met their preferences 
and priorities (Carr et al., 2003; Kotronoulas et al., 2017; 2017b; Ruland, 1998; Ruland et al., 1997). 
 
Procedures 
All eligible patients were thoroughly informed about the purposes and procedures of the study, and 
provided written informed consent. Patients participated in the study over four, equally spaced 
(monthly) time-points. This timeline was chosen to allow sufficient time for feasibility testing, whilst 
minimising the attrition rate. Each patient received the intervention twice. Each intervention session 
was followed by a follow-up assessment that enabled investigation of changes in supportive care 
needs and associated outcomes to be examined over time. 
x Baseline/Intervention Session 1 (T1): One month after the multidisciplinary team meeting, 
when melanoma diagnosis had been confirmed following pathological assessment of the 
excised lesion, participants were asked to attend the clinic to receive the intervention. They 
completed the intervention PRO measures and the Supportive Care Needs Survey-Short 
Form 34 (SCNS-SF34) (Boyes et al., 2009) prior to their consultation with the nurse specialist. 
x Follow-up Assessment 1 (T2): Two months after the multidisciplinary team meeting, 
participants were sent the SCNS-SF34 to complete at home and return via pre-paid post. 
x Intervention Session 2 (T3): Three months after the multidisciplinary team meeting, 
participants attended the clinic for a second intervention session. This visit coincided with the 
standard review appointment as scheduled for patients with melanoma within the participating 
NHS board, which is set around the time of wide local excision and possibly lymph node 
removal. Patients completed the intervention PRO measures and the SCNS-SF34 prior to 
their consultation with the nurse specialist. 
x Follow-up assessment 2 (T4): Four months after the multidisciplinary team meeting, 
participants were sent a final SCNS-SF34 to complete at home and return via pre-paid post. 
At the end of the study, the nurse specialist and a subset of study participants were invited to one-to-
one, semi-structured, exit interviews to explore their opinions/views about the intervention and its 
perceived value in clinical practice and cancer care. 
 
Instrumentation 
To address the primary aim of the study (Research Questions 1-3), a combination of different sources 
were employed including clinical audit data, patient survey data (via an author-developed form), and 
interview data from patients and/or health professionals. Feasibility, acceptability and perceived value 
parameters included the following: recruitment/refusal rates; reasons for refusal; attrition rates and 
reasons for attrition; feasibility of eligibility criteria; number of eligible patients; required time and 
resources to recruit; missing data due to non-response (overall and per time-point); missing data 
within returned PRO measures; time to complete PRO measures; patient perceived burden; feasibility 
of time-points/timing of intervention; acceptability of time-points/timing of intervention; acceptability of 
PRO measures; estimated duration of intervention sessions; perceived usefulness/value of 
intervention; implementation of intervention; adherence to intervention; and number of delays in 
consultation appointments/cancellation of consultation appointments. A demographic and clinical 
characteristics form was used to collect baseline demographic/clinical data for each participant. 
7KH1&&1¶V'7	3&(National Comprehensive Cancer Network, 2012) consists of a visual analogue 
scale (thermometer) that measures patient distress (0-10) and a 21-item problem checklist that 
identifies specific etiologies of distress, including practical, spiritual, physical, emotional, and family 
problems. 
The SCNS-SF34 consists of 34 items, each of which asks respondents to indicate their level of need 
for help during the preceding month (Boyes et al., 2009) ,WHPV DUH VFDOHG IURP  WR   ³QRW
DSSOLFDEOH´  ³VDWLVILHG´  ³ORZ QHHG´  ³PRGHUDWH QHHG´  ³KLJK QHHG´ (DFK LWHP ZDV
FRQVLGHUHGWRUHSUHVHQW³VRPHXQPHWQHHG´LIDVFRUHRIRUZDVREWDLQHG,WHPVRQWKH6&16-
SF34 are grouped into 5 domains of need: health systems and information (11 items), psychological 
(10 items), physical and daily living (5 items), patient care and support (5 items), and sexuality (3 
items). The SCNS supplementary melanoma-specific module comprises 12 items, with wording and 
response format similar to the SCNS-SF34, that examine needs specific to people with melanoma 
(McElduff et al., 2004). 
 
Sample size 
Sample sizes of 24-50 participants have been recommended for early feasibility testing (Julious, 
2005; Sim and Lewis, 2012). Taking into consideration overall patient admissions and resource 
availability, we considered a sample size of 30 patients with melanoma adequate to explore 
feasibility of our intervention. In addition, 10 of all patients recruited were planned to be invited to 
participate in exit interviews. This sample size was regarded adequate based on the principles of data 
saturation and variability for thematic content analysis (Guest et al., 2006). 
 
Data analysis 
Feasibility evaluation: Descriptive statistics and graphs were used to analyse data relating to 
primary outcomes. Continuous and/or interval-ratio variables are presented as means, standard 
deviation (or medians, interquartile range depending on normality) and range. Categorical variables 
will be presented as frequencies and percentages. 
Outcomes evaluation: SCNS-SF34 data were analysed using descriptive statistics and graphs. 
Frequency counts for each response were generated to describe response patterns for all measures, 
and quantify missing data. Missing data within returned PRO measures were treated with mean 
substitution. Three missingness dummy variables were created (1=missing, 0=not missing) to 
examine whether significant differences between responders and non-responders at T2, T3 and T4 
existed on demographic, clinical and baseline SCNS-SF34 data. No skewed patterns of missing data 
due to non-response/attrition were found. Hence, data were considered to be missing at random, and 
regression imputation was used to replace them. Total and subscale scores were calculated where 
appropriate. Q-Q plots, histograms and Shapiro-:LON¶V WHVWVZHUH XVHG WRFKHFN WKHDVVXPSWLRQRI
normality in total scores. Deviations from normality were noted, therefore non-parametric tests were 
performed. Wilcoxon signed rank tests were used to investigate change in SCNS-SF34 domain 
scores from baseline (T1) to T2 and T4, and from T3 to T4. The extent of intervention-related change 
over time in patient supportive care needs was explored through calculation of Standardised 
Response Means (SRM) (Stratford and Riddle, 2005). SRM were calculated as the ratio of individual 
change to the standard deviation of that change (Crosby et al., 2003), after change scores (T2-T1, T4-
T3, T4-7 KDG EHHQ FDOFXODWHG 650 ZHUH LQWHUSUHWHG DV µWULYLDO¶  µVPDOO¶  WR 
µPRGHUDWH¶  WRRU ODUJH (Cohen, 1988). To avoid misinterpretation of SRM, the 
correlation between repeated measurements (baseline and follow-up) was used to determine the 
SRM and WKHQ&RKHQ¶VWKUHVKROGVZHUHDSSOLHG650ZDVVWDQGDUGLVHGE\DYDOXH¥-r), where r 
was the correlation between baseline and any follow-XSPHDVXUHPHQW650 650¥-r)) (Middel 
and van Sonderen, 2002). All tests were two-tailed at the 0.05 level of significance. IBM SPSS 
statistical software was utilised to aid analyses. 
Qualitative analysis of exit interviews: Interviews were audio-recorded and transcribed verbatim. 
Themed categories were identified by one researcher based on the research objectives. Thematic 
content analysis (Braun and Clarke, 2014, 2006) is a useful approach for answering questions about 
the salient issues for a particular group of respondents or for identifying typical responses. The 
software analysis package QSR NVivo was used to aid the organisation of the data. 
 
Results 
Between March 2016 and June 2016, 18 patients with melanoma were considered eligible and invited 
to the study. Eight patients declined participation. Reasons for refusal were lack of time (n=4), 
additional health issues (n=2), or lack of interest (n=2). The final sample consisted of 10 participants 
(55.6%). 
Participants were typically women (80%), aged 52 years, married or partnered (75%), employed 
(62.5%) and with college/university education (80%). Most participants resided 6-20 miles away from 
the hospital (Table 1). 
Melanoma diagnosis had been confirmed a median of 33 days before participation in the study. Eight 
out of ten participants had a stage I disease, and for seven out of ten the tumour was <1 mm thick 
(Breslow). Nine patients had undergone surgery, whilst six patients had also undergone wide local 
excision. ECOG performance status was assessed as very good (40%) to excellent (60%). 
 
Estimates of intervention feasibility (RQ 1) 
A recruitment rate of 55% (10/18) and an average recruitment pace of 2-3 participants per month 
were achieved. Four patients (40%) completed all 4 PRO measure assessments. 
The nurse specialist performed a total of 19 in-clinic patient assessments within a period of 6 months. 
Only one patient missed their follow-up intervention session, which had to be cancelled. A retention 
rate of 90% was therefore achieved. None of the other nine patients asked to re-schedule their 
appointment for the follow-up intervention session. Intervention sessions were not time recorded, but 
in their majority they lasted 10-30 minutes depending on the issues identified and discussed. Full 
documentation records (case report form data) were received for all 19 in-clinic assessments. 
Completeness of background data reached 96%. 
Participation rates during the study were variable (T2 60%; T3 80% of expected PRO measure packs 
returned). Three participants were lost to follow-up, but that was only at T4 (attrition rate 30%). No 
contact was made possible with these individuals, thus no reasons for attrition were recorded. An 
overall participation rate of 77.5% was achieved, with 31 PRO measure packs returned out of a 
maximum theoretical of 40 (Table 2). Completeness of intervention PRO measures reached 100% at 
baseline, and remained high at the time of intervention session 2 (98.8-100%). 
 
Intervention acceptability and perceived value (RQ 2 and 3) 
Exit interviews were conducted with the nurse specialist and a subsample of patients (n=6). Main 
themes included experiences of the intervention, needs raised during consultations, and experiences 
of involvement in research.  
All of the patients found the intervention PRO measures quick and easy to complete and understand:  
³«YHU\ TXLFNO\ DFWXDOO\ , ZDV TXLWH VXUSULVHG LW ZDV TXLFNHU WKDQ , ZDV H[SHFWLQJ >«@ ,
found it very easy to answer.´>3@³2KLWZDVHDV\>WRFRPSOHWH@QRLWGLGQ¶WWDNHDQ\WLPH
DWDOO«´[P3] 
³7KH\ZHUH DEVROXWHO\ ILQH >7KH\ WRRN@DERXW WHQPLQXWHVRU VR >WR ILOO RXW@« LWZDVFOHDU
and, you know, very well laid out´ [P4]  
Two patients also agreed that having a space for any additional comments at the end of the 
intervention PRO measures would be useIXO IRUSHRSOHWR ORJDQ\PRUHWKRXJKWV³Jot it down, yes, 
that would have been, probably be more helpful´>3@ 
3DWLHQWVDJUHHGWKDWWKHTXHVWLRQVDVNHGLQWKHLQWHUYHQWLRQ352PHDVXUHVZHUH³«WKHEDVLVIRUWKH
start of a conversation´>3@$OEHLWUHOHYant overall, question relevance was felt to be dependent on 
WKHLQGLYLGXDO¶VFLUFXPVWDQFHVDQGWLPLQJRIFRPSOHWLRQ 
³«DQG RQH GD\ , FDQ H[SHULHQFH WKUHH DQG IRXU GLIIHUHQW W\SHV R
 IHHOLQJV >«@ VR D ORW
depends on just what part o' the, time o' the day it is or how you're feeling.´>3@ 
³«ZKHUH,VDLGWKHUHZDVQRWKLQJ ,GLGQ¶W IHHODQ[LRXVDQG,GLGQ¶W IHHODQ\ WKDW ,QHHGHG
DQ\KHOSLWWKHQWKHQFKDQJHG«´>3@ 
Patients found that completing the PRO measures was useful in that it provided a record of their 
concerns, thereby overcoming the common and frustrating problem of forgetting to raise all their 
needs during a consultation, and only realising this at some later point after the consultation:  
³«EHFDXVHVRPHWLPHV\RX
UH\RX
UHLQWLPLGDWHGRU\Ru're distracted or what have you, and 
\RXFRPHRXWDQG\RX WKLQNDZZ ,PHDQW WRDVN«VRDQGVRDQG , WKLQN WKHFRQFHSW LV
JRRGEHFDXVHLWGRHVKHOSWRIRFXVRQDOOWKHDUHDV«´>3@ 
For other patients the questions allowed them to think about issues that they might not otherwise 
have raised:  
³0D\EH,ZRXOGQ¶WKDYHWKRXJKWDERXWLWLILI,KDGQ¶WKDGWKRVHTXHVWLRQQDLUHV >«@EXWZKHQ
you see it written down on paper you think oh no I, I do need more information on that´>3@ 
³It really helped me because it made me sit down and think of the things that were affecting 
PHDQG,PD\QRWKDYHLI,KDGQ¶WKDGWKHTXHVWLRQQDLUH´>3@ 
One patient also noted that being able to complete the questionnaire in a quiet room away from the 
bustle of the waiting area was YHU\KHOSIXOLQDOORZLQJWKHPWRJDWKHUWKHLUWKRXJKWV³doing it in a quiet 
HQYLURQPHQW,FRXOGVLWDQGWKLQN«´>3@ 
The range of needs set out in the DT&PC DQG6&160HODQRPDPRGXOH WKH\ ³covered everything 
likely to be a problem´>3@JDYHSDWLHQWVSermission and the confidence to discuss issues with the 
nurse specialist: 
³«WREHIDLUREYLRXVO\WKHUHZDVWKLQJVLQWKHUHWKDW,PHDQ,GLG
QDHNQRZ\RXFRXOGR
JRW
help for«´>3@ 
³, FDQ XQGHUVWDQG KRZ WKRVH TXHVWLRQV \RX NQRZ LI SHRSOH LI WKH\ DVNed them it would 
PDNHWKHPWKLQNDERXWZKDWWKH\QHHGHGDQGZKDWWKH\ZHUHJRLQJWKURXJK«´>3@ 
Patients praised the protected time with the nurse specialist, who could review their responses and 
SURYLGH LPPHGLDWH VXSSRUW ³The thing I liked about it was she was able to speak to me 
LPPHGLDWHO\«´ >3@$V DQ H[DPSOH RQH SDUWLFLSDQW GLVFXVVHG WKH HIIHFW RI WKH GLDJQRVLV RQ KHU
IDPLO\DQGKRZEHVWWRFRQYH\WKLVLQIRUPDWLRQWRKHU\RXQJFKLOGUHQ³Family, family was a problem 
>«@IRUWKHPWRUHDOLVHWKHVHULRXVQHVVRIWKHLOOQHVV«´>3@7KHnurse specialist acknowledged that 
this was a challenging topic, but was able to signpost services available to the patient. Another patient 
discussed their underlying difficulties with anxiety and depression. In this instance, the nurse 
specialist ZDVDEOHWRGLUHFWWKHSDWLHQW WRZDUGVXLWDEOHUHVRXUFHVDQGFRQWDFWHGWKHSDWLHQW¶V*3WR
provide early medical intervention.  
Consistently and most frequently, patients requested support with queries about the tumour, 
recurrence, skin surveillance, and sun protection. Addressing such and other needs during the 
FRQVXOWDWLRQ ZDV D SRVLWLYH H[SHULHQFH IRU PRVW SDWLHQWV ³was very helpful´ >3@ DQG SDWLHQWV ZHUH
generally very happy with the support offered:  
³[the nurse] gave me leaflets home to read, which helped me understand it [the cancer], so I 
ZDVSUHWW\KDSS\ZLWKHYHU\WKLQJVKHRIIHUHGRU>«@DQVZHU>HG@IRUPH´>3@ 
³«LIWKHUHZDVDQ\WKLQJRQWKHTXHVWLRQQDLUHWKDWZDVRXW\RXNQRZVKHDVNHGPHDERXWLW
and, you know, how GLG,IHHODERXWWKLVRUGLG,QHHGDQ\PRUHKHOS«´>3@ 
Patients expressed the view that the information offered during consultations provided them with 
reassurance about their situation:  
³«DQGVKHZDVVR UHDVVXULQJDQGDQG , VDLG WRKHU µKRZ GR , NQRw if, if this is going to 
FRPHEDFN"¶DQGVKHVDLGµEXW,
OOFKHFN¶´>3@ 
³,PHDQLWJLYHV\RXSHDFHR
PLQG«´>3@ 
³She [the nurse specialist@GLGSXWP\PLQGDWUHVW«´>3@ 
As a result, the experience of taking active part in the consultation with the nurse specialist was seen 
as very positive by most patients: 
³Oh, absolutely, definitely, because there's things I said to her or things she looked, you 
know, for me like checking my whole body for all my, the other moles that I had, nobody, 
there's nobody else would have done that really, none o' the doctors would have done that 
UHDOO\«´>3@ 
³,WKLQNWKHFRQFHSWLVYHU\JRRG«DQG,GRWKLQNWKDWLWZLOOKHOSSDWLHQWVWR]RQHLQRQWKH
DUHDVWKDWWKHUHDUHSUREOHPVDQG,WKLQNWKDWLVQHHGHG«´>3@ 
³MeetiQJ WKH QXUVH ZDV >«@ UHDOO\ YHU\ YHU\ KHOSIXO 
FDXVH VKH ZDV DEOH WR LGHQWLI\
VWUDLJKWDZD\ZKDW,ZDVWKLQNLQJDQGIHHOLQJ>«@DQG,IHOWUHDOO\KDSS\RQFH,KDGOHIW>KHU@
>«@DQG,WKLQNWKHTXHVWLRQQDLUHRSHQHGWKDWRXWWRHQDEOHWKDW´>3@ 
Timing of consultations was seen as important, too. The nearer to treatment the more relevant the 
questions on the PRO measures were:  
³7KHUHZHUHVRPHTXHVWLRQV >«@VNLQVRUHQHVV >«@ WKDWSUREDEO\ZRXOGKDYHEHHQPRUH
more applicable shortly after I had the procedure done and not like a few months after it.´
[P1] 
³[The questions] were relevant because it was at very early stages of my melanoma, so 
there were lots of different things that were relevant to how I was feeling at that time´>3@ 
The nurse specialist agreed that seeing patients too soon (e.g. on the day of their diagnosis) was not 
useful as the diagnosis had still not sunk in. She also felt that one month post-diagnosis was the best 
time to see patients, but no later than six weeks.  
³«SUREDEO\WKH PRQWKGRZQWKHOLQHZKHUHWKH\
YHKDGWLPHWRWKLQNDERXWLW«SHUKDSVJLYH
them a, a phone to say that I'm here and that I will be sending an appointment, if you've any 
TXHVWLRQVZULWHWKHPGRZQ«´>1@ 
This was borne out by one patient, who due to a number of unfortunate circumstances, did not 
receive her consultation until 10 weeks after treatment. She felt that this was far too late to address 
KHUQHHGV³«E\WKHWLPH,ZDVVHHQWKHUHZDVQRQHHGIRUDQ\WKLQJ´>3@ 
The nurse specialist described how the PRO measures were useful in directing the patients to 
express their actual needs and her to offer support relevant to those needs. 
³«DQG , WKLQN DV D KHDOWKFDUH SURIHVVLRQDO ZH DUH D ELW SDWHUQDOLVWLF DQG ZH WKLQN WKLV LV
what they [the patients] need to know, or what we think they need to know, so for me it, it, it 
GLUHFWHGWREHUHOHYDQW WRWKHSDWLHQW >«@VR, IRXQG LWGLUHFWHGP\FRQVXOWDWLRQSUHWW\ZHOO´
[N1] 
The nurse specialist noted that what she considered important clinically and what was important to 
the patient did not always tally. This was evident among patients with thin melanomas and thick 
melanomas. Whereas, she as a health professional would not consider the issue of cancer recurrence 
a high priority with people with thin melanomas, worry about recurrence was raised by all of the 
patients that took part in the study. This finding led the nurse specialist to re-examine her practice and 
³«LWKDVPDGHPHORRNDWSHRSOHDVLQGLYLGXDOVDQGQRWMXVWDVDGLDJQRVLV´>1@ 
Being given the PRO measure to review prior to consultation allowed the nurse specialist time to 
FRQVLGHU KHU UHVSRQVH UDWKHU WKDQ WKH FRQVXOWDWLRQ EHLQJ ³«DOO UHDFWLRQ´ >1@ 8VH RI WKH 352
measures also gave the nurse specialist the opportunity to suggest resources that patients could 
utilise to address any priority needs.  
³I think it's given me an opportunity to signpost to Maggie's or signpost to The Haven, or 
even MASScot as well´>1@ 
Overall, the nurse specialist felt that using the PRO measures in her consultations was useful, but the 
biggest challenge she faced was the time and effort to recruit patients into the study: 
³I would say the hardest thing for me was trying to get it within my normal working week, that 
ZDVWKHKDUGWKLQJDQG,WKLQN>«@RQHRIWKHKDUGHVWWKLQgs was the recruiting´>1@ 
 
Prevalence of supportive care needs (RQ 4) 
During intervention session 1, an average of 8 needs per patient (range 2-18) were reported via the 
intervention PRO measures (3.6 needs per patient on the DT&PC; 4.4 needs per patient on the 
SCNS-Melanoma), accounting for a total of 79 reported needs across the study sample. Two (20%) 
participants reported 0-5 needs, 7 (70%) participants reported 6-10 needs, and 1 (10%) participant 
reported more than 10 needs. These figures slightly dropped to an average of 7.5 needs per patient 
(0-20) at the follow-up intervention session (4.5 needs per patient on the DT&PC; 3 needs per patient 
on the SCNS-Melanoma; total 60 needs; overall 25% reduction from T1 to T3). Three (37.5%) 
participants reported 0-5 needs, 3 (37.5%) participants reported 6-10 needs, and 2 (25%) participants 
reported more than 10 needs. 
During intervention session 1, the most prevalent supportive care needs were information, practical 
(treatment decisions), emotional (fears, nervousness, worry) or physical (fatigue, pain, sleep) needs 
(Table 3). Participants indicated a need for more information on a variety of health- and disease-
related topics, but mainly information about the risk of recurrence and possible outcomes when 
melanoma spreads from the skin (70%), and how and when to perform skin examinations (60%).  
During the follow-up intervention session, a shift towards more emotional needs (worry, nervousness) 
was noted. Interestingly, additional emotional issues, not previously reported, were reported by 25% 
of the sample (Table 3). These included fears, sadness and loss of interest in usual activities. Some 
physical needs (fatigue, pain/skin soreness) and information needs (recurrence, spread, surgical 
removal of lymph nodes) were also evident (reported by 37.5% of the sample).  
During intervention session 1, the nurse specialist discussed on average 2 topics (range 1-5; total 23) 
of supportive care needs with patients. Information gleaned from the case report form indicated that at 
this time the main topics of discussion in patient-nurse specialist interactions revolved around risk of 
recurrence, information, skin protection, and emotional issues (Table 4). On average, 2 topics (range 
1-2; total 12) per intervention session were discussed at follow-up, mainly focussing on emotional 
issues and pain management, although advice on skin examination/protection and the possibility of 
recurrence and spread of the tumour was also requested and offered. 
 Over-time changes in supportive care needs (RQ 5) 
A downward trend in SCNS-SF34 domain scores was noted over time (Figure 1). The only exception 
was psychological needs. After an initial decrease at T2, psychological needs steadily increased from 
T3 to T4, reaching baseline levels at T4. 
From T1 to T2, a statistically significant reduction in all domain scores, expect physical needs, was 
noted (Table 5). The greatest reduction (large SRM) was in domain scores for psychological and 
sexuality needs. 
From T3 to T4, non-statistically significant reductions in domain scores were found for information 
(small SRM) and physical needs (trivial SRM), whereas scores remain unchanged for patient care 
and support and sexuality needs (trivial SRM). 
Overall, a sizable reduction from T1 to T4 was observed in domain scores for information needs (large 
SRM; p<0.05). A moderate, yet not significant, reduction in domain scores for sexuality needs was 
also found. To a smaller extent, non-statistically significant reductions were also seen in patient care 
and support and sexuality needs (small SRM; p>0.05) (Table 5). 
 
Discussion 
This study recognised the importance of understanding the patient perspective of living with a 
diagnosis of melanoma, and ensuring that patient preferences and priorities are effectively 
incorporated in the delivery of supportive care services (National Cancer Action Team, 2013). To this 
effect, we introduced nurse-led and PRO-measures-driven consultations in routine clinical practice to 
identify and address the supportive care needs of people with newly diagnosed melanoma. We 
anticipated that this model would be of benefit in the following areas: (a) identification of previously 
undetermined issues; (b) enhancement of person-centred, supportive care; (c) quicker and more 
comprehensive management of supportive care needs; and (d) adoption of a shared model of care 
and partnership working between patients and health care professionals. In practice, we evidenced 
that the consultations appeared to be feasible and highly acceptable to both patients and clinicians, 
whilst there was preliminary evidence that this type of intervention could be associated with: 
x A sizeable reduction in the extent of information needs from the point of initial diagnosis 
throughout the first four months post-diagnosis, and 
x Reduction in the extent of psychological, patient care and support and sexuality needs in the 
month following the baseline intervention session.  
A modest recruitment rate of 56% may have been the result of a challenging period that deterred 
some patients from considering participation. Variable recruitment rates (ranging from >25% to >80%) 
have been reported in the few studies that have evaluated interventions to meet the supportive care 
needs of people with different types of cancer (Harrison et al., 2011; Kotronoulas et al., 2017; 2017b; 
Young et al., 2010), and the timing of intervention delivery does seem to play a role. Although the 
face-to-face nature of the intervention sessions was highly regarded, alternative options (e.g. 
telephone or video calls) could have allowed for easier patient access (Cox et al., 2017). In contrast, 
retention rate was near perfect, reaching 90% for intervention attendance, which is also higher than 
similar rates reported in other supportive care intervention studies (Harrison et al., 2011; Young et al., 
2010). Moreover, attrition was kept below 25%. Potential reasons may include the relatively short 
follow-up and the timing of the intervention, which was endorsed by participants as highly relevant in 
exit interviews.  
Session delivery, in-clinic performance, and data completeness were highly satisfactory. Given the 
minimal research support offered to the skin cancer nurse specialist, such performance estimates 
have greater significance and applicability to clinical practice. That said, it also became apparent that 
single-handedly delivering a time-intensive intervention may challenge adequate testing and 
implementation. With increased patient volumes and advanced nursing roles in force (e.g. skin 
surveillance, lymph node checks, skin protection and self-examination education) (Skripnik Lucas et 
al., 2016), reviewing and attending to individual patient healthcare needs had to be limited to priority 
needs only and concluded within a short time space. It is thus important to identify ways to either 
bring the intervention down to a delivery schedule that is more manageable for lone providers or 
ensure that adequate resources for nursing support are available. For instance, use of automated 
reports/summaries/graphs of expressed needs as part of an electronic platform could provide for a 
less time-consuming and more comprehensive means of PRO data interpretation and patient-clinician 
communication (Jensen et al., 2014). We believe that, by applying the intervention in real-life clinical 
circumstances and by keeping research support to a minimum, we were able to establish a realistic 
view of the facilitators and barriers of implementing this intervention within the participating NHS 
board. 
The intervention was highly acceptable to both patients and clinicians. Completeness of PRO and 
case report form data exceeded 90% both within and across time-points. In exit interviews, patients 
and the nurse specialist expressed positive opinions about the intervention. Patients endorsed the 
standardised use of an easy-to-use pack of supportive care need PRO measures as a means to help 
them shortlist, report and prioritise their needs, also confirming that no need is too unimportant to be 
discussed with the nurse specialist. The timing of the intervention was also perceived as appropriate 
and relevant. The nurse specialist viewed engagement in the PRO-measures-drive consultations as a 
highly structured and patient-centred activity that allowed her to get more detailed information about 
SDWLHQWV¶ H[SHULHQFHVSUHSDUHKHUVHOI WR UHVSRQG UDWKHU WKDQ ³UHDFW´ to expressed needs, and tailor 
VXSSRUW WR WDFNOH WKHVH QHHGV DFFRUGLQJ WR SDWLHQWV¶ SUHIHUHQFHV 1RWDEO\ WKH XVH RI WKH 352
measures helped the nurse specialist to see how preconceptions about the level of need of certain 
patient groups could lead to suboptimal delivery of care. Consistent with current evidence (Hetz and 
Tomasone, 2012), people with thin melanomas (and for this reason, with better prognosis) expressed 
fears of recurrence at the same frequency and intensity as those with thicker tumours. When we 
statistically compared these two groups, this same pattern emerged: on average, patients had the 
same anxieties, concerns and needs regardless of prognosis. From a training point of view, this 
realisation helped the nurse specialist WRFKDQJHKHU³WKRXJKWSDWWHUQ´WRIRFXVPRUHRQWKHSDWLHQWV¶
expressed needs than her own beliefs about what these needs must be.  
As with similar research, no specific clinical algorithms, guidelines or training were given to the nurse 
specialist DERXWKRZWRGHDOZLWKSDWLHQWV¶QHHGV (Kotronoulas et al., 2014). Nonetheless, the nurse 
specialist drew on her clinical expertise and was able to use her own resources or make appropriate 
referrals to support organisations such as Macmillan Cancer Support 
(https://www.maggiescentres.org/) or Melanoma Action and Support Scotland (MASScot; 
https://masscotcharity.wordpress.com/). Signposting patients to appropriate services after an initial 
assessment was particularly helpful when the nurse specialist was faced with the more sensitive, 
demanding and challenging needs of patients, such as patiHQWV¶ QHHG IRUKHOS WRH[SODLQFDQFHU WR
their children. Bringing up cancer diagnosis with the family (especially at school or under school age 
children) is a well-known concern and potentially distressful act for patients regardless of type of 
cancer (Asbury et al., 2014; Ewing et al., 2016), and one that professionals in the medical and nursing 
sciences may struggle to help with (Banerjee et al., 2016). Expert support provided by the afore-
mentioned services (in the form of one-to-one counselling or peer support, or via group therapy) is 
indispensable at the community level. Nonetheless, supporting hospital nursing staff (especially those 
more junior ones) with formal training and a toolkit of available resources, and/or deploying in-hospital 
counselling services to out-patient clinics could further promote intervention applicability and 
acceptability.  
In absolute terms, the number of expressed needs per participant at baseline intervention session 
was moderate, with only a slight reduction at the follow-up session. Both intervention sessions were 
purposely planned to be delivered at two critical time-points, which people with a new diagnosis of 
melanoma find challenging, perhaps for different reasons. The baseline intervention session was set 
around 4 weeks post-melanoma diagnosis, a period when patients struggle to makes sense of a life-
disrupting situation (Hajdarevic et al., 2014). Similar to previous research (Beesley et al., 2015; 
Bonevski et al., 1999), our participants did express a need for more information about a great deal of 
issues surrounding their diagnosis and requested support with making treatment decisions. Whilst 
emotional needs were also evident (Kasparian et al., 2009), they were far more prominent at the 
follow-up intervention session, which was set around the time of wide local excision. It was interesting 
to see how participants focussed more on their fears and anxieties that preceded and/or followed 
surgery, as well as their physical symptoms (skin soreness, fatigue, sleeplessness) that manifested in 
relation to the operation. In contrast, information needs abated. This could be due to an actual shift in 
priorities as well as intervention effects taking place, whereby information needs were sufficiently 
addressed by the nurse specialist. These observations support our conclusion that the timing of the 
intervention was indeed appropriate, and allowed the nurse specialist to tailor nursing actions to 
SDWLHQWV¶XQLTXHQHHGVDWDSHULRGRIWLPHZKHUHLQFUHDVHGFOLQLFian support was critical. 
The large effect size in the reduction in psychological/emotional needs from T1 to T2 could well mean 
that introducing the intervention at the immediate post-diagnosis period is of utmost benefit. This is 
supported by similar findings on other needs domains, symptom severity and satisfaction with care. In 
terms of emotional support, by providing reassurance and reliable information, our intervention 
SRVVLEO\KHOSHGSDWLHQWV¶WRFRQWUROWKHLUDQ[LHW\DQGIHDURIWKHXQNQRZQDVWKH\awaited removal of 
the tumour (Hajdarevic et al., 2014). However, the overall curvilinear pattern of change in 
psychological/emotional needs may suggest that if any sustainable effects were to take place, on-
going emotional support by the multidisciplinary team is required in the period surrounding wide local 
excision. Of note, pDUWLFLSDQWV¶ LQIRUPDWLRQ QHHGV VLJQLILFDQWO\ GHFUHDVHG IURP 7 WR 7 7KLV
potentially means that any emotional issues were related more to the overall hardship experienced 
living with a melanoma diagnosis than to lack of information. PatientV¶ needs in the physical, patient 
care support and sexuality domains also showed a gradual decline over time, but especially from T1 
to T2. From T3 to T4 (follow-up intervention session), scores on the latter two domains of need 
remained unchanged, which could be interpreted as no added effect of the intervention at T3. 
 
Strengths and limitations 
In this feasibility study, we followed a collaborative approach, engaging in early discussions with 
patient representatives and members of the clinical team that enabled us to customise and refine 
DVSHFWV RI WKH LQWHUYHQWLRQ LQ DQ DWWHPSW WR PHHW XVHUV¶ SUHIHUHQFHV H[SHFWDWLRQV DQG SULRULWLHV
Moreover, we employed different sources of information to comprehensively investigate feasibility and 
acceptability of the intervention, including observation, questionnaire and interview data. Finally, 
evaluation of the intervention with minimal research support and clinical practice assimilation 
conditions allowed for a realistic intervention evaluation within the participating NHS board. 
A number of key limitations warrant comment. Neither PRO measure completion nor consultation 
appointments were formally timed, but we only relied on retrospective accounts of duration. However, 
none of our participants reported the intervention as time-consuming. With a small sample size like 
this, the reliability of feasibility estimates may be questioned. Relatedly, although we were able to 
provide estimates of responsiveness to change for all PRO measures, SRMs may be artificially low or 
high given the small sample size that has limited heterogeneity in demographic/clinical characteristics. 
Finally, this was a single-centre study, thus reflecting current facilitators and barriers in the 
implementation of the intervention within this particular NHS board. Whether feasibility and 
acceptability of the intervention is similar in diverse clinical contexts remains unknown and 
generalizability is limited. 
 
Implications 
Implementing nurse-led, PRO-measure-driven consultations may be helpful in addressing the 
supportive care needs of people with newly diagnosed melanoma in clinical practice. If regularly 
audited, PRO data can provide important insight into priority supportive care needs of people treated 
for newly diagnosed melanoma. Special attention should be given to salient patient needs, including 
help to deal with fear of recurrence, need for more information, advice and guidance around skin 
protection, help to deal with emotional issues such as sadness and anxiety, and help with pain 
management. 
A number of actions could enhance feasibility and applicability of this model. These include (a) formal 
clinician training in the management of supportive care needs and a toolkit for signposting to available 
resources; (b) technology solutions to collect, synthesise and deliver PRO data to clinicians; (c) 
employing phone or Skype calls for consultation delivery; (d) revised intervention delivery schedules 
that allow for flexibility for lone providers (e.g. combine in-clinic with home-based sessions, increase 
the time interval between consecutive sessions, or investigate a single-session model); and (e) 
availability of adequate resources for nursing support. 
A pilot randomised controlled trial is warranted to provide preliminary evidence on the effectiveness of 
this intervention in relation to important patient behaviours (e.g. regularity of self-examination; 
adherence to skin protection recommendations) and patient outcomes (e.g. supportive care needs, 
self-efficacy, psychosocial adjustment, anxiety, relapse/survival). In addition, the feasibility and 
acceptability of the use of automated reports/summaries/graphs of expressed needs based on the 
use of electronic platforms to administer PRO measures should be explored as a less time-consuming 
and more comprehensive means of data interpretation and patient-clinician communication. 
 
Conclusions 
The use of PRO measures in nurse-led consultations to identify and address the supportive care 
needs of people with newly diagnosed melanoma appear to be feasible in clinical practice and 
acceptable to both patients and clinicians. This study re-confirms that nurse specialists are key 
professionals in the delivery of supportive care. It also suggests that, when structured through 
systematic use of PR2PHDVXUHVQXUVLQJFDUHFDQEHWDLORUHGWRDSHUVRQ¶VXQLTXHVXSSRUWLYHFDUH
needs. This can tentatively be followed by sizable reductions in said needs, also increasing patient 
satisfaction with care. Whilst our findings do provide evidence to support the future use of PRO 
measures in this area, the results of this study are still tentative and warrant confirmation in a larger 
study. 
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Figure legends 
 
Figure 1. Over-time change in supportive care needs based on SCNS-SF34 domain scores (Notes: 
PSYCH ± Psychological needs; INFO ± Information needs; PHYS ± Physical needs; PCS ± Patient 
care and support needs; SEX ± Sexuality needs). 
 
 
 
 
 
 
Tables 
 
 
Table 1. Demographic/clinical characteristics of the study sample (n=10) 
Variable 
 
 
Age (years) M (SD) 51.8 (14.2) 
Median 52.5 
Range 30-70 
 
n (%) 
Age (years) <40 2 (20.0) 
40-49 2 (20.0) 
50-59 2 (20.0) 
60-69 3 (30.0) 
 1 (10.0) 
Gender Female 8 (80.0) 
Educational attainment High School 2 (20.0) 
Some college 6 (60.0) 
University 2 (20.0) 
Employment (n=8) Employed 5 (62.5) 
Retired 3 (37.5) 
Marital status (n=8) Married/partnered 6 (75.0) 
Divorced 1 (12.5) 
Widowed 1 (12.5) 
Distance from hospital 1-5 miles 3 (30.0) 
6-20 miles 7 (70.0) 
Cancer staging I 8 (80.0) 
II 2 (20.0) 
Tumour thickness (in 
%UHVORZ¶VGHSWK 
PP 7 (70.0) 
1.01-3.00 mm 3 (30.0) 
Surgery Yes 9 (90.0) 
Wide local excision Yes 6 (60%) 
Chemotherapy Yes 0 (0.0) 
Radiotherapy Yes 0 (0.0) 
Supportive care Yes 1 (10.0) 
Any comorbidities Yes 1 (10.0) 
ECOG performance status 
(baseline) 
0 (fully active) 6 (60.0) 
1 (restricted in strenuous 
physical activity) 
4 (40.0) 
Notes: ECOG ± Eastern Cooperative Oncology Group; M ± Arithmetic 
mean; SD ± Standard Deviation 
 
 
Table
Table 2. Return, completeness and attrition rates for all PRO measures 
Parameter T1 T2 T3 T4 Total Intervention PRO measures 
PRO measures packs returned 10/10 6/10 8/10 7/10 31/40 
Missing data within returned PRO 
measures due to non-response 
out of total number of available 
data at Tx 
     
DT&PC 1/210 - 4/168 - 5/378 
SCNS-Melanoma 0/120 - 0/96 - 0/216 
SCNS-SF34 2/340 0/204 0/272 1/238 3/1054 
Missing data due to attrition out of 
theoretical maximum of available 
data at Tx 
0/770 268/770 134/770 201/770 603/3080 
Notes: PRO ± Patient-reported outcomes; DT&PC ± Distress Thermometer and Problem Checklist; SCNS-
Melanoma ± Supportive Care Needs Survey-Melanoma module; SCNS-SF34 ± Supportive Care Needs Survey-
Short Form 34; M ± Arithmetic mean; SD ± Standard Deviation; Tx ± Time-point. 
 
 
Table 3. Ranking of the most prevalent supportive care needs reported on the DT&PC and SCNS-
Melanoma during intervention sessions 1 and 2. 
Intervention session 1 (n=10) Intervention session 2 (n=8) 
DT&PC DT&PC 
Median distress score 3.5 (range 0-6) Median distress score 3.0 (0-6) 
Need Ranking n (%) Need Ranking n (%) 
Treatment decisions (PP) 1 3 (30%) Worry (EP) 1 5 (62.5%) 
Fears (EP) 1 3 (30%) Nervousness (EP) 2 3 (37.5%) 
Nervousness (EP) 1 3 (30%) Fatigue (PhP) 2 3 (37.5%) 
Worry (EP) 1 3 (30%) Pain (PhP) 2 3 (37.5%) 
Fatigue (PhP) 1 3 (30%) Sleep (PhP) 3 2 (25%) 
Pain (PhP) 1 3 (30%) Indigestion (PhP) 3 2 (25%) 
Sleep (PhP) 1 3 (30%) Treatment decisions (PP) 3 2 (25%) 
Indigestion (PhP) 2 2 (20%) Fears (EP) 3 2 (25%) 
Memory/concentration (PhP) 2 2 (20%) Sadness (EP) 3 2 (25%) 
Skin dry/itchy (PhP) 2 2 (20%) Loss of interest in usual 
activities (EP) 3 2 (25%) 
SCNS-Melanoma SCNS-Melanoma 
1HHGDWOHDVW³ORZ´ Ranking n (%) 1HHGDWOHDVW³ORZ´ Ranking n (%) 
More information about the 
risk of recurrence of 
melanoma. 
1 7 (70%) Skin soreness. 1 3 (37.5%) 
More information about 
possible outcomes when 
melanoma has spread from 
the skin. 
1 7 (70%) 
More information about the 
risk of recurrence of 
melanoma. 
1 3 (37.5%) 
To be informed about how 
and when to check your skin 
for changes. 
2 6 (60%) 
To be informed about the 
need for surgical removal 
of lymph nodes. 
1 3 (37.5%) 
To be informed about the 
need for surgical removal of 
lymph nodes. 
3 5 (50%) 
More information about 
possible outcomes when 
melanoma has spread from 
the skin. 
1 3 (37.5%) 
More information about non-
surgical treatment of 
melanoma (chemotherapy, 
immunotherapy). 
3 5 (50%) 
To be informed about the 
need for surgical treatment 
of melanoma of the skin. 
2 2 (25%) 
To be informed about things 
you can do for skin 
protection. 
4 4 (40%) 
To be informed about how 
and when to check your 
skin for changes. 
2 2 (25%) 
Skin soreness. 5 3 (30%) 
Access to a second opinion 
about your condition or 
treatment if you want one. 
2 2 (25%) 
More information about the 
unwanted effects of surgical 
treatment. 
5 3 (30%) 
More information about the 
unwanted effects of 
surgical treatment. 
2 2 (25%) 
Notes: DT&PC ± Distress Thermometer and Problem Checklist; SCNS-Melanoma ± Supportive Care Needs 
Survey-Melanoma module; PP ± Practical problems; EP ± Emotional problems; PhP ± Physical problems. 
 
 
 
Table 4. Topics of discussion between patients and the CNS during intervention sessions 1 and 2 
Intervention session 1 (n=10) Intervention session 2 (n=8) 
 Risk of recurrence (x4)  Anxiety/worry (x3: anxiety about prognosis; worry 
about skin exposure; anxiety about results of 
SLNB) 
 Information (x4) (More information about possible 
outcomes when melanoma spread; How and 
when to check for skin changes; Information on 
melanoma; Lack of information pre-surgery) 
 Pain (x2) (Skin soreness; pain in right chest wall) 
 Things to do for skin protection (x3)  Risk of recurrence (x2) 
 Nervousness, anxiety depression (x2)  Skin surveillance/examination 
 Unwanted effects of surgical treatment  Things to do for skin protection 
 Loss of interest in usual activities  Removal of lymph nodes 
 Sleep  Appearance of scar 
 Cosmetic appearance of scar  
 Decisions made: Patient decided not to have 
SLNB 
 
 Time delay seeing CNS  
 Lymphoedema  
 Dealing with children  
 Skin surveillance  
 Pain  
Notes: SLNB ± Sentinel lymph node biopsy; CNS ± Cancer nurse specialist. 
 
 
 
Table 5. SCSN-SF34 domain scores and SRM  
Parameter  PSYCH INFO PHYS PCS SEX 
T1 domain score M (SD) 32.3 (16.2) 28 (10.3) 19 (20.5) 13 (12.1) 11.7 (10.5) 
Median 33.8 25 12.5 15.0 16.7 
Range 10-55 13.6-45.5 0-70 0-25 0-25 
T2 domain score M (SD) 11.8 (8.3) 12 (5.7) 6 (10.5) 3.5 (6.3) 0 (0) 
Median 8.8 15.1 0 0 0 
Range 0-25 0-45.5 0-30 0-15 0 
T3 domain score M (SD) 21.5 (13.6) 13.7 (11.1) 14 (16) 9 (13.7) 5 (9) 
Median 25 11.4 10 0 0 
Range 2.5-37.5 0-36.4 0-50 0-35 0-25 
T4 domain score M (SD) 29.3 (23) 8 (10.2) 9 (14.7) 9.5 (14.4) 5 (10.5) 
Median 26.3 2.3 0 0 0 
Range 0-67.5 0-25 0-45 0-35 0-25 
T1-T2 SRM  -1.18 -0.63 -0.63 -0.67 -0.78 
T3-T4 SRM  0.24 -0.27 -0.16 0.05 0.00 
T1-T4 SRM  -0.08 -0.99 -0.37 -0.40 -0.60 
T1-T2 changea  -2.71** -2.20* -1.90 -2.00* -2.27* 
T3-T4 changea  -0.91 -1.12 -0.93 0 0 
T1-T4 changea  -0.87 -2.50* -1.54 -0.81 -1.79 
aWilcoxon signed ranks test (Z statistic) 
*p<0.05; **p<0.01; ***p<0.001 
Notes: SCNS-SF34 ± Supportive Care Needs Survey-Short Form 34; PSYCH ± Psychological needs; INFO ± 
Information needs; PHYS ± Physical needs; PCS ± Patient care and support needs; SEX ± Sexuality needs; 
SRM ± Standardised Response Mean; M ± Arithmetic mean; SD ± Standard Deviation. 
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